Delivery Order SPE2DR25D3017-SPE2DR26F3EH0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Mifepristone 300 mg tablets (28-count) with a ceiling value of $69,408.71. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $80,243.07 to AmerisourceBergen Drug Corp for the supply of Mifepristone 300 mg tablets (quantity 28) on October 21, 2025, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mifepristone 300 mg tablets in a 28-day supply quantity, with a ceiling value of $84,653.44. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's broader pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of mifepristone 300 mg tablets, a medication used for certain medical purposes. The contract has a ceiling value of $81,104.15 and is a firm-fixed-price contract. The contract is not set-aside and is therefore open to full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of MIFEPREX 200 MG TABLETS. The contract has a ceiling value of $1,032.00 and is a firm fixed price delivery order contract with an ultimate completion date of August 22, 2024. The award date is August 1, 2024, and there is no set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,032.00 firm fixed-price delivery order is for the supply of MIFEPREX 200 MG tablets. The award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Korlym (mifepristone) 300 mg tablets in quantities of 28 units under a firm fixed-price contract valued at $12,619.24. This non-set-aside, competitively awarded delivery order is scheduled for completion by December 16, 2025, with performance conducted from the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a discrete transaction on...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Misoprostol 100 microgram tablets in unit dose packaging of 100 units. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,319.56 and is scheduled for completion by September 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $41,791.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside contract, issued as a child delivery order under a larger contract vehicle, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on August 18, 2025, for an amount of $39,640.32 under a firm fixed-price contract. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract is scheduled for completion by August 19, 2025,...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3EH0Delivery Order
The Defense Logistics Agency awarded a $69,729.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mifepristone 300 mg tablets (28-count) with an ultimate completion date of December 5, 2025. The award, issued on December 4, 2025, is non-set-aside and competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible procurement mechanism designed to meet diverse federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $69.7k | 12/3/25 |